fourteen patients with cirrhosis and subclinical hepatic encephalopathy were randomised to treatment with lactitol or lactulose for a 2-month period during which they were monitored clinically , by electroencephalography and by manually administered and computer-based psychometric testing .
C0019151
hepatic encephalopathy
C0022957
lactulose